Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:OLMA News 10 December 2025 - 29 January 2026

Olema Pharmaceuticals (OLMA) stock jumps 6% in a weak market — what to watch next

Olema Pharmaceuticals (OLMA) stock jumps 6% in a weak market — what to watch next

Olema Pharmaceuticals shares rose 5.8% to $25.99 Thursday afternoon, adding about $127 million in market value as broader indexes fell. Trading volume reached 926,000 shares. No new company news emerged, but traders are watching for Olema’s March update and progress on its late-stage palazestrant trial. The company reported over $500 million in cash and equivalents as of Dec. 31, 2025.
29 January 2026
··
OLMA stock jumps 10% into JPMorgan week — what to watch for Olema Pharmaceuticals

OLMA stock jumps 10% into JPMorgan week — what to watch for Olema Pharmaceuticals

Olema Pharmaceuticals shares jumped 9.8% to $28.08 Friday, with 2.5 million shares traded ahead of the CEO’s Jan. 13 presentation at the J.P. Morgan Healthcare Conference. Citi, UBS, and Piper Sandler issued bullish ratings and price targets up to $60, citing upcoming trial data and potential catalysts. Olema raised $218.5 million in November. The company has no approved products and is advancing two breast cancer drug candidates.
11 January 2026
·
Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open

Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open

NEW YORK, Dec. 28, 2025, 6:44 a.m. ET — Market closed Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) heads into the final trading days of 2025 with investors trying to separate two very different realities: an explosive year-to-date run that put the breast-cancer biotech firmly on the growth-stock map—and a sharp late-December pullback that has reset near-term expectations. With U.S. markets closed for the weekend and set to reopen Monday, December 29, traders will be watching whether OLMA can stabilize after Friday’s decline and whether fresh headlines (or filings) emerge that could shift sentiment in either direction. Where OLMA stands heading into
28 December 2025
··
Olema Pharmaceuticals (OLMA) Stock Update: Weekend Snapshot, Insider Sales, Analyst Targets, and Key Catalysts Ahead of Monday

Olema Pharmaceuticals (OLMA) Stock Update: Weekend Snapshot, Insider Sales, Analyst Targets, and Key Catalysts Ahead of Monday

NEW YORK, Dec. 27, 2025, 8:26 PM ET — Market closed Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is heading into the weekend with investors weighing a sharp Friday pullback against a still-staggering multi-month run, a cluster of insider-trading filings, and a set of analyst price targets that continue to imply significant upside—if Olema’s late-stage breast cancer program delivers on its timeline. With U.S. equity markets closed Saturday and Sunday, the next meaningful price discovery for OLMA will come when regular trading resumes Monday, Dec. 29, at 9:30 a.m. ET. New York Stock Exchange OLMA stock price today: where Olema closed, and
28 December 2025
Olema Pharmaceuticals (NASDAQ: OLMA) Stock: Latest News, Analyst Forecasts, and What’s Driving the Volatility on December 19, 2025

Olema Pharmaceuticals (NASDAQ: OLMA) Stock: Latest News, Analyst Forecasts, and What’s Driving the Volatility on December 19, 2025

Olema Pharmaceuticals, Inc. trades under the ticker OLMA (not “OLEM”) on Nasdaq. GlobeNewswire+1 On Friday, December 19, 2025, the stock was sharply lower intraday—$28.89, down $1.92 (-6.23%) at the latest published trade time in the market data feed, after opening $31.22 and swinging between $31.95 and $28.89. That kind of whiplash has become the defining feature of OLMA lately: it’s a clinical-stage oncology name where headline risk (trial readouts—yours or your rivals’) and financing mechanics (offerings, cash runway narratives) can move the stock fast. Below is a detailed roundup of the most relevant news, forecasts, and analysis available as of
19 December 2025
···
Olema Pharmaceuticals (OLMA) Stock Hits New 52‑Week High on December 10, 2025: What Investors Need to Know

Olema Pharmaceuticals (OLMA) Stock Hits New 52‑Week High on December 10, 2025: What Investors Need to Know

Published: December 10, 2025 Olema Pharmaceuticals Stock Rallies to Fresh Highs Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), which now brands itself as Olema Oncology, is having another breakout session on December 10, 2025. During Wednesday’s trading, OLMA: Over the past 12 months, OLMA’s share price has climbed from below $3 to nearly $30, according to Danelfin and CoinCodex ranges, reflecting a more than tenfold move at the extremes. Danelfin AI+1 Today’s spike is not a random move. It’s being driven by a cluster of catalysts that all hit investors’ screens at once: positive read‑through from a Roche breast cancer drug trial,
10 December 2025
·

Stock Market Today

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

7 February 2026
Cisco shares closed up 3% at $84.82 Friday after a volatile week for tech stocks. The company will report quarterly results Feb. 11, with analysts expecting EPS of $1.02 on $15.12 billion revenue. U.S. jobs and inflation data, delayed by the federal shutdown, are also due next week. About 23.9 million Cisco shares traded Friday.
AMD stock rebounds 8% after post-earnings slump as payrolls, CPI loom

AMD stock rebounds 8% after post-earnings slump as payrolls, CPI loom

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, rebounding after a 13% plunge earlier in the week on weak guidance and AI competition fears. The Philadelphia semiconductor index rose 5.7% as chip stocks led a broader market rally. Investors are awaiting next week’s U.S. payrolls and inflation data, which could shift rate expectations for tech.
Go toTop